Jeffrey Sall, PhD, MD
Professor
Anesthesia
School of Medicine

415-476-0322

Education & Training

Show all (5) Hide

  • Postdoctoral Studies Anesthesia & Perioperative Care University of California 2007
  • Residency Anesthesia & Perioperative Care University of California 2006
  • Internship Internal Medicine University of Iowa 2003
  • M.D./Ph.D. Medicine/Neuroscience University of Iowa 2002
  • B.S. Biology University of Nebraska 1994

Websites

Show all (3) Hide

Grants and Projects

Show all (7) Hide

  • A Multicenter, Double-blind, Randomized and Placebo-controlled Pivotal Phase 3 Study to Evaluate the Safety and Efficacy of T89 in Prevention and Treatment of Acute Mountain Sickness (AMS) After Rapid Ascent, Tasly Pharmaceutical, 2021-2025
  • Comprehensive analysis of developmental cannabis exposure on brain, immune and sensory systems, California Bureau of Cannabis Control, 2022-2024
  • A Phase 3/4 Randomized, Double-blind, Dose-ranging Study of the Safety and Efficacy of Dexmedetomidine (Dex) Used with Propofol (Pro) as Needed for Procedural Sedation of Pediatric Subjects =1 Month to <17 Years of Age Undergoing Mri Scans, Pfizer, 2020-2022
  • A Double-blind, Randomized and Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of T89 in Prevention and Treatment of Acute Mountain Sickness During Rapid Ascent, Tasly Pharmaceutical, 2017-2021
  • Prevention of cerebral injury in pediatric diabetic ketoacidosis, American Diabetes Association, 2017-2021
  • Testosterone's role in sex-specific outcomes after early anesthesia, NIH, 2015-2021
  • Volatile anesthetic alteration of neural precursor cell cycle and fate decisions, NIH, 2010-2015

Publications (41)

Top publication keywords:
Methyl EthersSpatial MemoryAnesthesiaRats, Sprague-DawleyMaze LearningPropofolMemory DisordersNeurotoxicity SyndromesSymportersAnesthetics, InhalationIsofluraneResearch ReportSolute Carrier Family 12, Member 2NeuroprotectionAnesthetics

Show all (36 more) Hide